Beyza Ayazgök

557 total citations
19 papers, 383 citations indexed

About

Beyza Ayazgök is a scholar working on Pharmacology, Computational Theory and Mathematics and Physiology. According to data from OpenAlex, Beyza Ayazgök has authored 19 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 12 papers in Computational Theory and Mathematics and 7 papers in Physiology. Recurrent topics in Beyza Ayazgök's work include Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (12 papers) and Alzheimer's disease research and treatments (6 papers). Beyza Ayazgök is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (12 papers) and Alzheimer's disease research and treatments (6 papers). Beyza Ayazgök collaborates with scholars based in Türkiye, Iran and Saudi Arabia. Beyza Ayazgök's co-authors include Tuba Tüylü Küçükkılınç, Alireza Foroumadi, Mehdi Khoobi, Hamid Nadri, Keriman Ozadali‐Sari, Oya Ünsal Tan, Ayla Balkan, Hamid Forootanfar, Leili Jalili‐Baleh and Saeed Emami and has published in prestigious journals such as European Journal of Medicinal Chemistry, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Journal of Molecular Structure.

In The Last Decade

Beyza Ayazgök

19 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beyza Ayazgök Türkiye 13 233 177 173 78 76 19 383
Kamila Czarnecka Poland 14 173 0.7× 144 0.8× 159 0.9× 97 1.2× 142 1.9× 36 541
Paula Zaręba Poland 11 217 0.9× 162 0.9× 103 0.6× 102 1.3× 143 1.9× 31 390
Digambar Kumar Waiker India 12 192 0.8× 141 0.8× 132 0.8× 71 0.9× 116 1.5× 21 362
Elena Bovina Russia 5 180 0.8× 115 0.6× 90 0.5× 134 1.7× 93 1.2× 11 346
Tomasz Wichur Poland 10 339 1.5× 249 1.4× 164 0.9× 126 1.6× 130 1.7× 14 427
Lucie Drtinová Czechia 10 417 1.8× 240 1.4× 164 0.9× 122 1.6× 138 1.8× 14 569
Baichen Xiong China 9 233 1.0× 157 0.9× 89 0.5× 68 0.9× 144 1.9× 13 450
Ondřej Benek Czechia 16 243 1.0× 162 0.9× 206 1.2× 149 1.9× 245 3.2× 32 658
Shoaib Manzoor India 9 159 0.7× 102 0.6× 165 1.0× 49 0.6× 111 1.5× 12 347
Ranyao Yang China 15 164 0.7× 196 1.1× 56 0.3× 90 1.2× 257 3.4× 19 602

Countries citing papers authored by Beyza Ayazgök

Since Specialization
Citations

This map shows the geographic impact of Beyza Ayazgök's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beyza Ayazgök with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beyza Ayazgök more than expected).

Fields of papers citing papers by Beyza Ayazgök

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beyza Ayazgök. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beyza Ayazgök. The network helps show where Beyza Ayazgök may publish in the future.

Co-authorship network of co-authors of Beyza Ayazgök

This figure shows the co-authorship network connecting the top 25 collaborators of Beyza Ayazgök. A scholar is included among the top collaborators of Beyza Ayazgök based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beyza Ayazgök. Beyza Ayazgök is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Küçükkılınç, Tuba Tüylü, Beyza Ayazgök, Hamid Nadri, et al.. (2022). Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’s Disease. Frontiers in Chemistry. 9. 810233–810233. 13 indexed citations
2.
Jalili‐Baleh, Leili, Hamid Nadri, Hamid Forootanfar, et al.. (2021). Chromone–lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities. DARU Journal of Pharmaceutical Sciences. 29(1). 23–38. 23 indexed citations
3.
Hamzeh‐Mivehroud, Maryam, Salar Hemmati, Javid Shahbazi Mojarrad, et al.. (2021). Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies. Archiv der Pharmazie. 354(7). e2000453–e2000453. 11 indexed citations
4.
Ayazgök, Beyza, et al.. (2020). Ketamine induces rapid and sustained antidepressant-like effects in chronic pain induced depression: Role of MAPK signaling pathway. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 100. 109898–109898. 42 indexed citations
5.
Hamzeh‐Mivehroud, Maryam, Salar Hemmati, Javid Shahbazi Mojarrad, et al.. (2020). Design, synthesis, and biological evaluation of novel indanone-based hybrids as multifunctional cholinesterase inhibitors for Alzheimer's disease. Journal of Molecular Structure. 1229. 129787–129787. 18 indexed citations
6.
Tan, Oya Ünsal, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Ayla Balkan, & Keriman Ozadali‐Sari. (2019). Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer's disease. MedChemComm. 10(6). 1018–1026. 15 indexed citations
7.
Ayazgök, Beyza & Tuba Tüylü Küçükkılınç. (2019). Neurotoxic effects of bisphenol A on SH-SY5Y neuroblastoma cells via nitric oxide. Journal of Research in Pharmacy. 23(3). 354–359. 5 indexed citations
8.
Jalili‐Baleh, Leili, Hamid Nadri, Tuba Tüylü Küçükkılınç, et al.. (2019). New classes of carbazoles as potential multi-functional anti-Alzheimer’s agents. Bioorganic Chemistry. 91. 103164–103164. 21 indexed citations
9.
Tan, Oya Ünsal, et al.. (2019). Design and Synthesis of 2-Substitutedphenyl Benzo[D]Thiazole Derivatives and Their β-Amyloid Aggregation and Cholinesterase Inhibitory Activities. Pharmaceutical Chemistry Journal. 53(4). 322–328. 4 indexed citations
10.
Nadri, Hamid, Hamid Forootanfar, Alieh Ameri, et al.. (2019). 3‐Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi‐Target‐Directed Ligands against Alzheimer's Disease. Chemistry & Biodiversity. 16(5). e1800436–e1800436. 12 indexed citations
11.
Dadashpour, Sakineh, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, et al.. (2019). Discovery of Novel 1,2,4-triazolo-1,2,4-triazines with Thiomethylpyridine Hinge Binders as Potent c-Met Kinase Inhibitors. Future Medicinal Chemistry. 11(10). 1119–1136. 11 indexed citations
12.
Valipour, Mehdi, et al.. (2019). Synthesis and Biological Assessment of 2-Hydroxyiminoethanones as Anti-Inflammatory and β-Amyloid Aggregation Inhibitors.. PubMed. 18(3). 1288–1298. 2 indexed citations
13.
Ayazgök, Beyza & Tuba Tüylü Küçükkılınç. (2018). Low‐dose bisphenol A induces RIPK1‐mediated necroptosis in SH‐SY5Y cells: Effects on TNF‐α and acetylcholinesterase. Journal of Biochemical and Molecular Toxicology. 33(1). e22233–e22233. 13 indexed citations
14.
Jalili‐Baleh, Leili, Hamid Forootanfar, Tuba Tüylü Küçükkılınç, et al.. (2018). Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds. European Journal of Medicinal Chemistry. 152. 600–614. 63 indexed citations
15.
Jalili‐Baleh, Leili, Hamid Nadri, Hamid Forootanfar, et al.. (2018). Novel 3-phenylcoumarin–lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease. Bioorganic Chemistry. 79. 223–234. 41 indexed citations
16.
Mirjalili, Bi Bi Fatemeh, Hamid Nadri, Hamid Forootanfar, et al.. (2018). Synthesis and biological evaluation of new N-benzylpyridinium-based benzoheterocycles as potential anti-Alzheimer’s agents. Bioorganic Chemistry. 83. 559–568. 28 indexed citations
17.
Ozadali‐Sari, Keriman, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Ayla Balkan, & Oya Ünsal Tan. (2017). Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles. Bioorganic Chemistry. 72. 208–214. 37 indexed citations
18.
Küçükkılınç, Tuba Tüylü, Beyza Ayazgök, Farshad Homayouni Moghadam, et al.. (2017). Synthesis and neuroprotective activity of novel 1,2,4-triazine derivatives with ethyl acetate moiety against H 2 O2 and Aβ-induced neurotoxicity. Medicinal Chemistry Research. 26(11). 3057–3071. 13 indexed citations
19.
Tan, Oya Ünsal, Keriman Ozadali‐Sari, Beyza Ayazgök, Tuba Tüylü Küçükkılınç, & Ayla Balkan. (2017). Novel 2-Arylbenzimidazole derivatives as multi-targeting agents to treat Alzheimer’s disease. Medicinal Chemistry Research. 26(7). 1506–1515. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026